BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Affymax, Inc. and Takeda Pharmaceutical Co. Ltd. Announce Analyses from OMONTYS® (peginesatide) Injection Phase 3 Dialysis Studies Presented at 2012 American Society of Nephrology Meeting

  November 2, 2012

   · 

  1 min read
• Business

  Benten BioServices Receives Additional Funding

  November 2, 2012

   · 

  1 min read
• Pharm Country

  Precision Therapeutics, Inc. Release: New Study Shows Association Between ChemoFx® Results and Recurrence Free Survival

  November 2, 2012

   · 

  1 min read
• Business

  Alnylam Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2012 Financial Results

  November 2, 2012

   · 

  1 min read
• Business

  Anacor Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results Conference Call and Webcast

  November 2, 2012

   · 

  1 min read
• Business

  Vertex Pharmaceuticals (MA) Reports Third Quarter 2012 Financial Results and Recent Progress in Development Programs

  November 2, 2012

   · 

  1 min read
• Business

  MannKind Corporation Reports 2012 Third Quarter Financial Results

  November 2, 2012

   · 

  1 min read
• Genetown

  Ironwood Pharmaceuticals to Host Webinar on Accounting Treatment for LINZESS™ (Linaclotide)

  November 2, 2012

   · 

  1 min read
• Business

  Taro Pharmaceutical Industries Ltd. Provides Second Quarter and Fiscal Year to Date Results

  November 2, 2012

   · 

  1 min read
• Business

  Thoratec Corporation Reports Third Quarter Results

  November 2, 2012

   · 

  1 min read